Literature DB >> 10960440

The impact of interferon gamma receptor expression on the mechanism of escape from host immune surveillance in hepatocellular carcinoma.

M Nagao1, Y Nakajima, H Kanehiro, M Hisanaga, Y Aomatsu, S Ko, Y Tatekawa, N Ikeda, H Kanokogi, Y Urizono, T Kobayashi, T Shibaji, T Kanamura, S Ogawa, H Nakano.   

Abstract

Interferon gamma (IFN-gamma) plays an important role in host defense mechanism and participates in the progression of chronic liver disease. IFN-gamma exerts its pleiotrophic effects by transcriptional regulation of expression of numerous genes, such as major histocompatibility complex (MHC) class I and Fas, through interaction with IFN-gamma receptor (IFN-gamma-R). Although hepatocytes in normal liver express weak or no IFN-gamma-R, those in acute and chronic liver disease up-regulate its expression. A study using IFN-gamma-R alpha-chain knock-out mice revealed the actions of IFN-gamma on tumor cells as an extrinsic tumor-suppressor mechanism. However, it is unclear whether or how hepatocellular carcinoma (HCC) blocks the signal transduction of IFN-gamma to evade host immune surveillance. We examined the expression of IFN-gamma-R and IFN-gamma-inducible genes in 44 cases with HCC using real-time reverse-transcriptase polymerase chain reaction (RT-PCR) and immunohistochemistry. In noncancerous liver tissues (n = 38), IFN-gamma-R expression on the cell surface was up-regulated in 27 cases. In IFN-gamma-R-negative cases (n = 15), tumor size was larger (P =.032), serum alpha-fetoprotein (AFP) level was higher (P =.001), intrahepatic and extrahepatic metastasis was more common (P =.044 and.013, respectively), and Ki-67 labeling index (LI) was higher (P =.041), compared with IFN-gamma-R-positive cases. Accordingly, the evasion mechanism may play an important role in progression, especially metastasis, in HCC. The significant correlation between the status of IFN-gamma-R and the expression of Fas and MHC implies that the loss of IFN-gamma-R might contribute to the mechanism of escape from host immune rejection in HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10960440     DOI: 10.1053/jhep.2000.16470

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  22 in total

1.  Deletion of IFNγ enhances hepatocarcinogenesis in FXR knockout mice.

Authors:  Zhipeng Meng; Xiaoqiong Wang; Yichao Gan; Yunfeng Zhang; Hong Zhou; Carl Van Ness; Jun Wu; Guiyu Lou; Hua Yu; Chao He; Rongzhen Xu; Wendong Huang
Journal:  J Hepatol       Date:  2012-06-21       Impact factor: 25.083

2.  Modulation of gamma interferon receptor 1 by Mycobacterium tuberculosis: a potential immune response evasive mechanism.

Authors:  Amit Singhal; Anand Jaiswal; Virendra K Arora; Hanumanthappa K Prasad
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

Review 3.  Regulation of hepatocyte fate by interferon-γ.

Authors:  Christopher J Horras; Cheri L Lamb; Kristen A Mitchell
Journal:  Cytokine Growth Factor Rev       Date:  2011-02-18       Impact factor: 7.638

Review 4.  Immunobiology of hepatocellular carcinoma.

Authors:  Tobias Flecken; Hans Christian Spangenberg; Robert Thimme
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

Review 5.  Immunobiology of hepatocarcinogenesis: Ways to go or almost there?

Authors:  Pavan Patel; Steven E Schutzer; Nikolaos Pyrsopoulos
Journal:  World J Gastrointest Pathophysiol       Date:  2016-08-15

6.  Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B.

Authors:  Li-Yuan Wang; Yu-Chen Fan; Jing Zhao; Xiang-Fen Ji; Kai Wang
Journal:  Clin Exp Med       Date:  2017-11-21       Impact factor: 3.984

7.  Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.

Authors:  Gang Chen; Feng-jiang Zhang; Ming Gong; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

8.  Down-regulation of beta-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study.

Authors:  Yong-Qiang Weng; Shuang-Jian Qiu; Yin-Kun Liu; Jia Fan; Qiang Gao; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2007-07-07       Impact factor: 4.553

9.  Lysyl Oxidase-Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis.

Authors:  Hor-Yue Tan; Ning Wang; Cheng Zhang; Yau-Tuen Chan; Man-Fung Yuen; Yibin Feng
Journal:  Hepatology       Date:  2021-05-21       Impact factor: 17.425

10.  Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories.

Authors:  Yan-Gao Man; Alexander Stojadinovic; Jeffrey Mason; Itzhak Avital; Anton Bilchik; Bjoern Bruecher; Mladjan Protic; Aviram Nissan; Mina Izadjoo; Xichen Zhang; Anahid Jewett
Journal:  J Cancer       Date:  2013-01-05       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.